Results 61 to 70 of about 44,494 (287)

OS RECURSOS ESTRATÉGICOS E AS INSTITUIÇÕES DE ENSINO SUPERIOR: ESTUDO DE CASO EM UMA UNIVERSIDADE DO SUL DO BRASIL

Revista Gestão Universitária na América Latina, 2016
Competition among higher education institutions (HEIs), the evolution in learning methods and information technologies drive HEIs and lead them to increasingly intense challenges.
Roberto Birch Gonçalves, Guilherme Bergmann Borges Vieira, Luciane Stallivieri   +2 more
doaj  

1(OH) vitamin D3 supplementation improves the sensitivity of the immune-response during Peg-IFN/RBV therapy in chronic hepatitis C patients-case controlled trial. [PDF]

PLoS ONE, 2013
OBJECTIVE: 1,25(OH)2 vitamin D3 can affect immune cells. However, the mechanism responsible for the favorable effects of 1(OH) vitamin D3, which becomes 1,25(OH)2 vitamin D3 in the liver, is not clear.
Yasuteru Kondo, Takanobu Kato, Osamu Kimura, Tomoaki Iwata, Masashi Ninomiya, Eiji Kakazu, Masahito Miura, Takehiro Akahane, Yutaka Miyazaki, Tomoo Kobayashi, Motoyasu Ishii, Norihiro Kisara, Kumiko Sasaki, Haruo Nakayama, Takehiko Igarashi, Noriyuki Obara, Yoshiyuki Ueno, Tatsuki Morosawa, Tooru Shimosegawa   +18 more
doaj   +1 more source

Nature at Risk, Finance at Stake: A Systematic Literature Review of Biodiversity Risk in Finance Research

Business Strategy and the Environment, EarlyView.
ABSTRACT Biodiversity‐related financial risk is increasingly recognized not only as a market concern but as an ethical and systemic imperative for businesses and financial institutions. This systematic literature review synthesizes 103 peer‐reviewed studies to examine how biodiversity risk is conceptualized, measured, and integrated within financial ...
Thang Ngoc Dang, Monomita Nandy, Suman Lodh, Khaled Hussainey   +3 more
wiley   +1 more source

A nationwide assessment of hepatocellular adenoma resection: Indications and pathological discordance

Hepatology Communications, EarlyView., 2022
Abstract Hepatocellular adenomas (HCAs) are benign liver tumors associated with bleeding or malignant transformation. Data on the indication for surgery are scarce. We analyzed indications and outcome of patients operated for HCAs < 50 mm compared to HCAs ≥ 50 mm. Changes in final postoperative diagnosis were assessed.
Martijn P. D. Haring, Arthur K. E. Elfrink, Christiaan A. J. Oudmaijer, Paul C. M. Andel, Alicia Furumaya, Nenke de Jong, Colin J. J. M. Willems, Thijs Huits, Julie M. L. Sijmons, Eric J. T. Belt, Koop Bosscha, Esther C. J. Consten, Mariëlle M. E. Coolsen, Peter van Duijvendijk, Joris I. Erdmann, Paul Gobardhan, Robbert J. de Haas, Tjarda van Heek, Hwai‐Ding Lam, Wouter K. G. Leclercq, Mike S. L. Liem, Hendrik A. Marsman, Gijs A. Patijn, Türkan Terkivatan, Babs M. Zonderhuis, Izaak Quintus Molenaar, Wouter W. te Riele, Jeroen Hagendoorn, Alexander F. M. Schaapherder, Jan N. M. IJzermans, Carlijn I. Buis, Joost M. Klaase, Koert P. de Jong, Vincent E. de Meijer, the Dutch Benign Liver Tumor Group, R. B. Takkenberg, J. Verheij, O. M. van Delden, J. I. Erdmann, B. V. van Rosmalen, A. Furumaya, G. Kazemier, D. Ramsoekh, J. N. M. IJzermans, R. A. de Man, M. D. Doukas, M. G. Thomeer, A. J. Klompenhouwer, A. F. M. Schaapherder, M. E. Tushuizen, M. J. Coenraad, A. S. L. P. Crobach, M. C. Burgmans, S. Feshtali, M. M. E. Coolsen, M. Kramer, J. C. Beckervordersandforth, I. V. Samarska, C. van der Leij, R. Miclea, J. H. W. de Wilt, P. B. van den Boezem, E. T. T. L. Tjwa, I. Munsterman, S. Vos, S. van Koeverden, V. E. de Meijer, F. J. C. Cuperus, R. J. de Haas, E. W. Duiker, M. P. D. Haring   +70 more
wiley   +1 more source

EVOLUÇÃO DA PESQUISA EM RBV: um estudo dos últimos EnANPAD’s

REBRAE, 2008
O objetivo do presente trabalho foi verificar a contribuição brasileira nos estudos de estratégia e enfoque na RESOURCE-BASED VIEW – RBV. O estudo visou expor e analisar a evolução da pesquisa em RBV no Brasil, a partir dos trabalhos selecionados e apresentados no EnANPAD.
Serra, Fernando A. Ribeiro, Ferreira, Manuel Portugal, Pereira, Maurício Fernandes, Lissoni, Juliano   +3 more
openaire   +3 more sources

A Natural Resource‐Based View of Circular Economy Practices in the Pharmaceutical Industry

Business Strategy and the Environment, EarlyView.
ABSTRACT Pharmaceutical industry is facing escalating environmental sustainability issues including gaseous emissions, waste generation, and excessive consumption of energy and non‐renewable materials. Nevertheless, the adoption of sustainable business models such as the circular economy (CE) is still in its infancy in this sector due to complex ...
Amna Farrukh, Muhammad Sohaib Sajjad
wiley   +1 more source

Therapeutic effectiveness of biosimilar standard interferon versus pegylated interferon for chronic hepatitis C genotypes 2 or 3

Brazilian Journal of Infectious Diseases, 2012
Background: Pegylated interferon (Peg-IFN) and standard interferon (IFN) play a significant role in the treatment of hepatitis C virus (HCV) infection. Biosimilar standard IFN is widely available in Brazil for the treatment of HCV infection genotypes 2 ...
Aline Gonzalez Vigani, Eduardo Sellan Gonçales, Maria Helena Postal Pavan, Flavia Genari, Raquel Tozzo, Maria Silvia Kroll Lazarini, Viviane Fais, Adriana Feltrin, Neiva Sellan Gonçales, Fernando Lopes Gonçales, Jr   +9 more
doaj   +1 more source

Exploring the Role of Green Training on Organizational Resilience: A Multisectoral European Analysis

Business Strategy and the Environment, EarlyView.
ABSTRACT The double transition paradigm has imposed to redefine the rules to compete. The demand for green skills, driven by European policy targets, currently outpaces the supply available in the labor market. This study surveys European companies across multiple sectors to assess the role of green training, a key element of green human resource ...
Giulia Alessandri, Fabio Iannone, Annamaria Pesci, Tiberio Daddi, Fabio Iraldo   +4 more
wiley   +1 more source

A hepatitis C virus (HCV) fertőzés pathogenesise: a genetikai és az immunológiai tényezők, valamint az oxidativ stress szerepe és a kórokozó virus sajátosságai, különös tekintettel a HCV-okozta betegségekben és a tünetmentes virushordozó állapotban = Pathogenesis of hepatitis C virus (HCV) infection: the role of the genetic and immunological factors, the oxidative stress and the viral features in the HCV-related diseases and in the symptomfree virus carriers [PDF]

, 2009
Genetikai, immunológiai és környezeti tényezők potenciális szerepe krónikus hepatitis C virus (HCV) infekcióban: összehasonlitó vizsgálatok aktiv HCV hepatitises betegekben és tünetmentes "egészséges" virushordozókban. 1.
Berki, Timea, Hunyady, Béla, Kalabay, László, Nagy, Zsuzsanna, Pár, Alajos, Pár, Gabriella   +5 more
core  

Timing for treatment of HCV recurrence after liver transplantation: the earlier the better. [PDF]

, 2016
HCV is the leading cause of death from liver disease and is the most common indication for a liver transplantation. Although HCV is a widespread health problem, disease management is particularly challenging in several key subpopulations, including liver
Burra, Patrizia, Russo, Francesco Paolo, Zanetto, A   +2 more
core   +1 more source